Intel (NASDAQ: INTC) fell about 4% on Monday — sliding as much as ~5% to $96.97 intraday before paring the loss — after it unveiled a proposed $15 billion underwritten sale of new common stock, per Bloomberg and Yahoo Finance. Underwriters hold a 30-day option for another $2.25 billion, which would push the raise to as much as $17.25 billion.

Why it dropped: this is dilution, plain and simple. Intel is printing new shares — roughly 3% more stock — so every existing holder's slice of the company shrinks by about that much. Tellingly, the rest of the chip pack didn't flinch: AMD, Nvidia and Broadcom held steady on the day, so this was an Intel-specific event, not a sector sell-off.

Why now — and why equity: Intel already lifted its 2026 capital-spending plan from $18B to about $20 billion, and this raise covers roughly 75% of that capex in one shot, earmarked for AI chips, custom silicon, advanced packaging and its contract-manufacturing (foundry) push. The tell is that Intel chose stock over debt: its shares have more than doubled in 2026, so selling equity near the highs is the cheapest money it can get.

The ripple: $20B of Intel capex flows straight to the toolmakers. The direct beneficiaries are the fab-equipment names — ASML (lithography), Applied Materials (AMAT) and Lam Research (LRCX) — which book the orders when Intel buys the machines that fill those fabs. More Intel spend, more tool revenue for them.

The one risk to watch: execution — and it has a concrete trigger. The bet only pays off if Intel turns this cash into a marquee external foundry customer; analyst Dan Niles flagged a foundry win as "imminent." Watch the offering's final pricing (a steep discount would signal weak demand) and any named big-customer announcement. Without one, $15 billion of fresh dilution just funds an unproven turnaround.

As of 11 Aug 2026, ~9:40 AM IST. Sources: Yahoo Finance, 24/7 Wall St, TS2. For discussion and education only — not investment advice. Verify before acting.